What is BioInetlli?
BioInetlli specializes in providing proprietary algorithms and databases tailored for the life science business market. Its solutions are designed to be an essential tool for sales and marketing efforts targeting a broad spectrum of entities, including government agencies, private biotech and biopharma firms, academic institutions, research institutes, venture capital firms, and numerous other life science funding sources. The company's core offering addresses the critical need for sophisticated big data analysis within a complex and rapidly evolving industry.
How much funding has BioInetlli raised?
BioInetlli has raised a total of $142K across 2 funding rounds:
Debt
$20K
Debt
$122K
Debt (2021): $20K with participation from PPP
Debt (2025): $122K led by Northeast Bank
Key Investors in BioInetlli
PPP
Public-Private Partnership
Northeast Bank
Northeast Bank, a financial institution, has provided debt financing to BioInetlli, supporting its operational and growth initiatives.
What's next for BioInetlli?
The large-scale, late-stage funding positions BioInetlli for significant expansion and market penetration. This capital infusion is expected to fuel further development of its data analysis algorithms, enhance its database capabilities, and broaden its market reach. The strategic nature of the recent investment suggests potential collaborations or integrations that could accelerate BioInetlli's mission to empower life science organizations with actionable insights. The company is poised to solidify its role as a key player in enabling data-driven decision-making across the life sciences ecosystem.
See full BioInetlli company page
